A meta-analysis involving more than 43,000 adults with obesity, suggests that obesity medications, such as GLP-1 drugs, could ...
In the first trial of microRNA inhibition to treat heart failure, a novel agent did not reduce left ventricular end-systolic ...
Analyses supporting the use of digitalis glycosides in patients with heart failure were presented in a Late-Breaking Science ...
The portable SGP device emits near-infrared light as a noninvasive autonomic neuromodulation strategy for suppressing ...
Major advances in cardiovascular devices and drugs were unveiled at recent medical meetings, including promising trial results for arrhythmia ablation systems, mitral valve replacement, and novel ...
Novartis, Amgen and Eli Lilly are among the pharmaceutical companies developing drugs to lower levels of a particularly bad form of cholesterol called Lp(a) and potentially prevent heart attacks. Lp(a ...
Tirzepatide, the drug behind blockbuster treatments like Zepbound and Mounjaro, is best known for driving significant weight loss. But new research suggests its benefits may extend well beyond the ...
Some vaccines, along with heart medications and other drugs, appear to have a protective benefit. By Dana G. Smith Getting your annual flu shot may come with a significant side benefit: helping to ...
Doctors have been drilled for decades on the four big risks for heart disease, which kills more Americans every year than any other illness. The fearsome foursome: hypertension, smoking, high levels ...
A powerful cholesterol-lowering drug may be changing the rules of heart disease prevention. Researchers found that evolocumab, typically used for people who already have cardiovascular disease, can ...
People who stop taking popular weight-loss and diabetes medications may lose out on any heart health benefits the medications provided. GLP-1 receptor agonists — such as semaglutide (Ozempic and ...
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac ...